Recent Articles
Avoid Nikola Stock Even As EV Holdings Remain Hot
Nikola never deserved to sport a $28 billion market cap and one could argue that NKLA stock doesn't deserve its current valuation of $8 billion either.
There’s No Need to Chase CIIG Merger Now
EV plays like CIIC stock went nuts near the end of 2020. Even with a pullback so far in 2021, investors can and should stay patient.
MoneyLine Podcast: The Healthcare Tech Stocks You Need to Know About
In this week's MoneyLine episode, Matt talks about a group of stocks that have been quietly growing since before the pandemic.
Buy Hims & Hers Stock for a Solid Play on Telehealth
With its focus on millennials, fast growing telemedicine play HIMS stock has plenty of room to run after its recent SPAC merger.
Don’t Get Suckered Into Ocugen Stock
OCGN stock has gone crazy amid a partnership to develop a Covid-19 vaccine. The problem is there's little evidence it will actually work.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
